Nonclinical Development & Toxicology
Safety questions.
A development plan.
DEP brings together the right expertise to assess nonclinical safety questions, interpret evidence, and manage the work needed for your next development decision.
Explore this service:
Before you spend, be sure™.
Define the safety question and the evidence it needs.
A molecule, an impurity concern, or a new result can raise questions about the nonclinical development path. DEP helps establish the scope and coordinate the right response.
Mutagenic impurity risk assessment
Review the available impurity information and relevant evidence, identify gaps, and develop a scoped assessment of the concern and recommended follow-up.
Genotoxicity assessment and interpretation
Bring expert judgment to available genotoxicity evidence, conflicting findings, or questions about what additional assessment may be needed.
Nonclinical safety strategy
Connect the safety questions to the program’s objectives, existing data, and next milestone. Prioritize the specialist review and work needed to support the development plan.
DEP leads the engagement
DEP is your point of contact. We assemble the appropriate experts, manage the project, and integrate their findings into a practical recommendation and plan for next steps.
Explore the approach and expertise
See how the work connects.
Read a fictional illustration of the team’s reasoning. It demonstrates an approach, not a client result or a fixed service package.
See how initial priorities are considered →Relevant expertise
Profiles describe relevant experience. The people involved, their availability, and their roles are confirmed for each engagement.
Find a useful starting point
What do you need help with?
Answer two short questions to explore relevant support. This is a conversation guide, not a scientific assessment. You can contact DEP at any point.
Scope and delivery
From the available evidence to the next step.
What you bring
The immediate question, program stage, relevant nonclinical or genotoxicity reports, available impurity and process information, prior assessments, and any relevant agency feedback. Confidential detail is shared through an agreed process.
What you receive
A scoped evidence and risk assessment, expert interpretation of the available findings, a prioritized gap list, and a recommended safety strategy or follow-up work plan. Where appropriate, outputs include a scientific rationale for discussion with regulatory specialists.
How DEP manages the work
DEP defines the question with you, brings together relevant toxicology and development expertise, and coordinates the analysis and any directed work needed. Appropriate testing providers generate additional data when justified. DEP reviews progress and explains what the findings mean for your next development decision.
The scope follows the specific safety question and evidence. Recommendations identify remaining uncertainties; they do not guarantee a regulatory outcome.
Before you spend, be sure™.
Start with the decision you need to make.
Tell us what you need help with, the question you have, or the milestone you’re working toward. DEP can help define the next steps and coordinate the work.
Drug Engine Pharma
You can contact DEP without sharing technical details.